NCT04245670进行中（未招募）不适用
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:A Phase II Study (5STAR-PC)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 75
- 试验地点
- 2
- 主要终点
- Acute Toxicity
研究概览
简要总结
Stereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions. Simultaneously treating the pelvic lymph nodes, prostate and MRI-nodule to a total dose of 25 Gy, 35 Gy and up to 50 Gy, respectively. The radiation will be given with 6-18 months of ADT.
5-fraction SABR is a feasible, well-tolerated, effective and cost effective treatment for high-intermediate and high risk prostate cancer with/without an image-guided intraprostatic boost.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Acute Toxicity
时间窗: Baseline to 3 months post completion of treatment
To document the acute urinary toxicity using the Common Terminology Criteria for Adverse Events (CTCAE v4.0) criteria
次要结局
- Economic analysis(Baseline to end of 5 year follow up)
- Quality of Life outcome(Baseline to end of 5 year follow up)
- Biochemical disease-free survival(Baseline to end of 5 year follow up)
- Quality of life outcome(Baseline to end of 5 year follow up)
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
5 Fractions of Pelvic SABR With Intra Prostatic SABRProstate CancerNCT02911636Andrew Loblaw30
招募中
2 期
Prostate SABR With Intra-Prostatic SABR BoostProstate CancerNCT04212715King Saud University30
招募中
2 期
Adjuvant Stereotactic Pelvic Irradiation in Endometrial CancerEndometrial CancerNCT04235179King Saud University30
已完成
不适用
MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate CancerProstate CancerNCT03664193Weill Medical College of Cornell University30
进行中（未招募）
2 期
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate CancerProstate CancerNCT04489745VA Greater Los Angeles Healthcare System72